These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25676594)

  • 21. Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery.
    Beck-Broichsitter M; Schweiger C; Schmehl T; Gessler T; Seeger W; Kissel T
    J Control Release; 2012 Mar; 158(2):329-35. PubMed ID: 22063006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of formulation variables on the morphology of biodegradable microparticles prepared by spray drying.
    Clarke N; O'Connor K; Ramtoola Z
    Drug Dev Ind Pharm; 1998 Feb; 24(2):169-74. PubMed ID: 15605447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amphotericin B-loaded polymeric nanoparticles: formulation optimization by factorial design.
    Carraro TC; Khalil NM; Mainardes RM
    Pharm Dev Technol; 2016 Mar; 21(2):140-6. PubMed ID: 25384838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexamethasone acetate encapsulation into Trojan particles.
    Gómez-Gaete C; Fattal E; Silva L; Besnard M; Tsapis N
    J Control Release; 2008 May; 128(1):41-9. PubMed ID: 18374442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrospray synthesis of monodisperse polymer particles in a broad (60 nm-2 μm) diameter range: guiding principles and formulation recipes.
    Almería B; Gomez A
    J Colloid Interface Sci; 2014 Mar; 417():121-30. PubMed ID: 24407667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization of the Büchi B-90 spray drying process using central composite design for preparation of solid dispersions.
    Gu B; Linehan B; Tseng YC
    Int J Pharm; 2015 Aug; 491(1-2):208-17. PubMed ID: 26070248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of post-emulsification drying processes on the microencapsulation of human serum albumin.
    Lane ME; Brennan FS; Corrigan OI
    Int J Pharm; 2006 Jan; 307(1):16-22. PubMed ID: 16274944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of differential drying techniques on PLGA nanoparticles containing hydrophobic and hydrophilic anticancer agents.
    Dhapare SS; Dash AK
    Ther Deliv; 2015 Jan; 6(1):27-39. PubMed ID: 25565439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer.
    Ahmed AR; Elkharraz K; Irfan M; Bodmeier R
    Pharm Dev Technol; 2012; 17(1):66-72. PubMed ID: 20854130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Factors of Importance for Spray Drying of Small Interfering RNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles for Inhalation.
    Dormenval C; Lokras A; Cano-Garcia G; Wadhwa A; Thanki K; Rose F; Thakur A; Franzyk H; Foged C
    Pharm Res; 2019 Aug; 36(10):142. PubMed ID: 31376020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoscale surface characterization and miscibility study of a spray-dried injectable polymeric matrix consisting of poly(lactic-co-glycolic acid) and polyvinylpyrrolidone.
    Meeus J; Chen X; Scurr DJ; Ciarnelli V; Amssoms K; Roberts CJ; Davies MC; van Den Mooter G
    J Pharm Sci; 2012 Sep; 101(9):3473-85. PubMed ID: 22447580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent.
    Mok H; Park TG
    Eur J Pharm Biopharm; 2008 Sep; 70(1):137-44. PubMed ID: 18515053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Definition of formulation design space, in vitro bioactivity and in vivo biodistribution for hydrophilic drug loaded PLGA/PEO-PPO-PEO nanoparticles using OFAT experiments.
    Simonoska Crcarevska M; Geskovski N; Calis S; Dimchevska S; Kuzmanovska S; Petruševski G; Kajdžanoska M; Ugarkovic S; Goracinova K
    Eur J Pharm Sci; 2013 Apr; 49(1):65-80. PubMed ID: 23439240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease.
    Lautenschläger C; Schmidt C; Lehr CM; Fischer D; Stallmach A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):578-86. PubMed ID: 24084650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spray-drying preparation of microparticles containing cationic PLGA nanospheres as gene carriers for avoiding aggregation of nanospheres.
    Takashima Y; Saito R; Nakajima A; Oda M; Kimura A; Kanazawa T; Okada H
    Int J Pharm; 2007 Oct; 343(1-2):262-9. PubMed ID: 17628365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rifapentine-loaded PLGA microparticles for tuberculosis inhaled therapy: Preparation and in vitro aerosol characterization.
    Parumasivam T; Leung SS; Quan DH; Triccas JA; Britton WJ; Chan HK
    Eur J Pharm Sci; 2016 Jun; 88():1-11. PubMed ID: 27049049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality by Design approach to spray drying processing of crystalline nanosuspensions.
    Kumar S; Gokhale R; Burgess DJ
    Int J Pharm; 2014 Apr; 464(1-2):234-42. PubMed ID: 24412337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Int J Pharm; 2010 Apr; 389(1-2):74-85. PubMed ID: 20085803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro degradation of nanoparticles prepared from polymers based on DL-lactide, glycolide and poly(ethylene oxide).
    Zweers ML; Engbers GH; Grijpma DW; Feijen J
    J Control Release; 2004 Dec; 100(3):347-56. PubMed ID: 15567501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises.
    Ungaro F; d'Angelo I; Miro A; La Rotonda MI; Quaglia F
    J Pharm Pharmacol; 2012 Sep; 64(9):1217-35. PubMed ID: 22881435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.